Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that the cytoplasmic zinc finger protein A20 functionally dampens inflammatory signals and apoptosis via inhibition of NF-kappaB activation and biochemically acts as a unique ubiquitin-modifying protein with deubiquitinating activity and ubiquitin ligase activity. However, the molecular mechanisms of A20-modulated signal transduction that influence normal immune responses or tumor immunity have not been fully elucidated. Using a yeast two-hybrid system to search for proteins interacting with A20, we identified one novel binding protein,
Ymer
.
Ymer
, which has been reported to be highly phosphorylated on tyrosine residues via EGF stimulation, bound to lysine (K)-63-linked
polyubiquitin
chain on receptor-interacting serine/threonine-protein kinase 1 (RIP1), which is essential for NF-kappaB signaling in collaboration with A20. A luciferase assay showed that NF-kappaB signaling was down-regulated by overexpression of
Ymer
, whereas knock-down of
Ymer
up-regulated NF-kappaB signaling even without stimulation. These findings demonstrate that
Ymer
is likely to be a negative regulator for the NF-kappaB signaling pathway.
...
PMID:Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. 1802 35
Cytoplasmic zinc finger protein A20 functionally dampens inflammatory signals and apoptosis via inhibition of NF-kappaB activation. We have reported that
Ymer
interacts with A20 and lysine (K)-63-linked
polyubiquitin
chain and that
Ymer
inhibits NF-kappaB signaling in collaboration with A20. It has also been reported that
Ymer
is phosphorylated by EGF stimulation. We found that
Ymer
was considerably phosphorylated on tyrosine residues also via Src family kinases such as Lck. A luciferase reporter assay showed that mutation of tyrosines on
Ymer
(YmerY217/279/304F) results in loss of the inhibitory activity for NF-kappaB signaling. Furthermore, a soft agar colony formation assay showed that the combination of SrcY527F and YmerY217/279/304F has no ability for anchorage-independent growth, suggesting that tyrosine phosphorylation of
Ymer
is important for inhibition of the NF-kappaB-mediated apoptotic pathway. These findings demonstrate that
Ymer
is likely to be a negative regulator for the NF-kappaB signaling pathway.
...
PMID:Inhibition of NF-kappaB signaling via tyrosine phosphorylation of Ymer. 1905 8